deltatrials
Unknown PHASE3 INTERVENTIONAL NCT00204087

Psychological Intervention for Persons in the Early Initial Prodromal State

Psychological Intervention for Persons at Risk of Psychosis in the Early Initial Prodromal State

Sponsor: Department of Psychiatry University of Bonn

Updated 5 times since 2017 Last updated: Jan 10, 2006 Started: Jan 31, 2001 Completion: Jun 30, 2005
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Psychosis and Schizophrenia and is currently ongoing. Department of Psychiatry University of Bonn leads this study, which shows 5 recorded versions since 2001 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 21 months · monthly snapshotUnknown

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    First recorded

Jan 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Department of Psychiatry University of Bonn
  • German Federal Ministry of Education and Research
  • German Research Network On Schizophrenia
  • Heinrich-Heine University, Duesseldorf
  • Ludwig-Maximilians - University of Munich
  • University of Cologne
Data source: University of Cologne

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations